Segra International | Natural Products Specialist Armin Prahst Joins Segra Advisory Board
Segra International is a specialist R&D company focused on Quality Management Systems and facilities for medicinal Cannabis and botanical tissue culture
Segra, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility
167
post-template-default,single,single-post,postid-167,single-format-standard,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Natural Products Specialist Armin Prahst Joins Segra Advisory Board

PRESS RELEASES

Natural Products Specialist Armin Prahst Joins Segra Advisory Board

Vancouver, BC, January 12, 2016 – Segra Biogenesis Corp is pleased to announce the appointment of Armin Prahst B.Sc., M.Sc., an international Natural Health Product specialist to the advisory board.

Mr. Prahst is a seasoned Scientist working for over 30 years in various positions in the Food, Beverage and Natural Health Product Industry. He graduated with a M.Sc. in Food Science from the University of British Columbia in 1994 and obtained his B.Sc. in 1992 from the University of Guelph. His passion is fermentation technology and food processing, which he nurtured working with various companies such as Granville Island Brewing and RJ Spagnols specifically in R&D and QC Senior positions. The last 15 years he has been operating his own business, Spagomed Laboratories, focusing on developing and marketing Natural Health Products in Canada and consulting to industry. He was one of the first
individuals to successfully create a retail line of fermented and conventionally extracted botanicals in North America. The IP that he created is currently utilized by Teawolf LLC, a highly successful botanical extract company that he co-founded and helped build as Technical Director since 2009. Mr. Prahst has a wide range of practical experience ranging from the agricultural field, to the lab bench and industrial processing over to the regulatory environment in Canada and the USA. His business travels brought him to China, Ecuador, Peru, Chile, the USA and many European countries enabling him to link not only interdisciplinary fields but also intercultural ones.

At Segra, we believe in only basing our products claims for efficacy and safety on validated scientific research, and in being transparent about the sources of the research with our customers. With the appointment of Mr. Prahst to the advisory board, the Company will be in a better position to commercialize products according to Company principles. For more information on the Segra management and advisory team visit http://segra-intl.com/team/.

Segra Biogenesis Corp. is an emerging specialist Research and Development Company focused on plantbased medicines, including medicinal Cannabis. Our team is driven by its experience in research and development work in medicine, genetics, cultivation techniques, natural medicines, biochemistry, agriculture and information technology. Segra’s goal is to research, develop, test and produce very unique and specific cultivars from the plant kingdom that are effective for specific ailments in medical patients.

Segra Biogenesis Corp
www.segra-intl.com

For Information Contact:
Todd McMurray
President
Email:todd@segra-intl.com